Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Share Buyback/Dividend

Re: Share Buyback/Dividend

posted on Jun 08, 2009 12:29PM

PTSC tried the dividend route twice in past, probably two years ago, which cost them $14 MM to do and I'm certain they wish they had it back, because it did absolutely nothing to increase the share price at the time.

Share
New Message
Please login to post a reply